Overview

On-Demand Use of Pantoprazole: Determinants for Chronic Use of Acid Suppressive Medication

Status:
Unknown status
Trial end date:
2005-09-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to investigate several aspects of chronic use of acid suppressing medication: dependence on maintenance therapy, the possibilities for on-demand use, and predictors (patient characteristics) for daily need, for on-demand use and for termination of chronic use.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
UMC Utrecht
Collaborator:
Takeda
Treatments:
Pantoprazole
Criteria
Inclusion Criteria:

- male and female (non-pregnant, non-lactating)out-patients between 18-75

- chronic users of acid suppressive therapy for at least 180 days over the last year

Exclusion Criteria:

- stage 3, 4 oesophagitis, Barrett's oesophagus, acute peptic ulcer

- gastric hypersecretory condition, predominantly IBS symptoms, previous
gastric/oesophageal surgery, pyloric stenosis

- severe, unstable comorbidities

- alarm symptoms

- malignancies in the past 5 years

- use of NSAID, systemic glucocorticoids, Cox-2 inhibitors, acetylsalicylic acid more
than 150 mg daily, drugs with pH-dependent absorption, anticholinergics